Skip to main content

Advertisement

Log in

A role for atm in E-cadherin-mediated contact inhibition in epithelial cells

  • Preclinical study
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

Ataxia telangiectasia is a hereditary pleiomorphic syndrome caused by loss of Atm, a phosphoprotein involved in multiple signaling pathways. Here, we propose a novel role for atm in cultured epithelial cells, namely the regulation of cell growth by contact inhibition. We show that atm is upregulated in epithelial cells reaching confluence. Conditional expression of the PI 3-Kinase domain of atm in non-confluent Tac-2 epithelial cells increases the expression of the anti-proliferative gene Tis-21 and downregulates key cell cycle regulator genes, such as cyclins A, B1, B2, E and E2. Finally, we demonstrate that upregulation of atm, and thus Tis-21, in confluent Tac-2 cells can be inhibited by an E-cadherin antibody blocking specifically homophilic E-cadherin interactions between adjacent cell surfaces. Altogether, these results suggest that atm could participate in a molecular pathway linking extracellular signalling to cell cycle control and may help further clarify the role of Atm in epithelial cell biology and carcinogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Rotman G, Shiloh Y (1998) ATM: from gene to functionHum Mol Genet 7(10):1555–1563

    Article  PubMed  CAS  Google Scholar 

  2. Swift (1990) Cancer predisposition of Ataxia-Telangiectasia heterozygotesCancer Genet Cytogenet 46:21–27

    Article  PubMed  CAS  Google Scholar 

  3. Gumy-Pause F, Wacker P, Sappino AP (2004) ATM gene and lymphoid malignanciesLeukemia 18(2):238–242

    Article  PubMed  CAS  Google Scholar 

  4. Easton DF (1994) Cancer risks in A-T heterozygotesInt J Radiat Biol 66(6 Suppl):S177–182

    Article  PubMed  CAS  Google Scholar 

  5. Izatt L, Greenman J, Hodgson S, Ellis D, Watts S, Scott G, Jacobs C, Liebmann R, Zvelebil MJ, Mathew C, Solomon E (1999) Identification of germline missense mutations and rare allelic variants in the ATM gene in early-onset breast cancerGenes Chromosomes Cancer 26(4):286–294

    Article  PubMed  CAS  Google Scholar 

  6. Broeks A, Urbanus JH, Floore AN, Dahler EC, Klijn JG, Rutgers EJ, Devilee P, Russell NS, van Leeuwen FE, van’t Veer LJ (2000) ATM-heterozygous germline mutations contribute to breast cancer-susceptibilityAm J Hum Genet 66(2):494–500

    Article  PubMed  CAS  Google Scholar 

  7. Maillet P, Bonnefoi H, Vaudan Vutskits G, Pajk B, Cufer T, Foulkes W, Chappuis PO, Sappino AP (2002) Constitutional alterations of the ATM gene in early-onset sporadic breast cancerJ Med Genet 39(10):751–753

    Article  PubMed  CAS  Google Scholar 

  8. Chen G, Lee E (1996) The product of the ATM gene is a 370-kDa nuclear phosphoproteinJ Biol Chem 271(52):33693–33697

    Article  PubMed  CAS  Google Scholar 

  9. Watters D, Khanna KK, Beamish H, Birrell G, Spring K, Kedar P, Gatei M, Stenzel D, Hobson K, Kozlov S, Zhang N, Farrell A, Ramsay J, Gatti R, Lavin M (1997) Cellular localisation of the ataxia-telangiectasia (ATM) gene product and discrimination between mutated and normal formsOncogene 14(16):1911–1921

    Article  PubMed  CAS  Google Scholar 

  10. Brown KD, Chakravarti A (1999) Multiple ATM-Dependent Pathways: An Explanation for PleiotropyAm J Hum Genet 64(1):46–50

    Article  PubMed  CAS  Google Scholar 

  11. Zakian VA (1995) ATM-related genes: what do they tell us about functions of the human gene? Cell 82(5):685–687

    Article  PubMed  CAS  Google Scholar 

  12. Bosotti R, Isacchi A, Sonnhammer EL (2000) FAT: a novel domain in PIK-related kinasesTrends Biochem Sci 25(5):225–227

    Article  PubMed  CAS  Google Scholar 

  13. Canman CE, Lim DS, Cimprich KA, Taya Y, Tamai K, Sakaguchi K, Appella E, Kastan MB, Siliciano JD (1998) Activation of the ATM kinase by ionizing radiation and phosphorylation of p53Science 281(5383):1677–1679

    Article  PubMed  CAS  Google Scholar 

  14. Baskaran R, Wood LD, Whitaker LL, Canman CE, Morgan SE, Xu Y, Barlow C, Baltimore D, Wynshaw-Boris A, Kastan MB, Wang JY (1997) Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiationNature 387(6632):516–519

    Article  PubMed  CAS  Google Scholar 

  15. Barlow C, Brown KD, Deng CX, Tagle DA, Wynshaw-Boris A (1997) Atm selectively regulates distinct p53-dependent cell-cycle checkpoint and apoptotic pathwaysNat Genet 17(4):453–456

    Article  PubMed  CAS  Google Scholar 

  16. Ewing CM, Ru N, Morton RA, Robinson JC, Wheelock MJ, Johnson KR, Barrett JC, Isaacs WB (1995) Chromosome 5 suppresses tumorigenicity of PC3 prostate cancer cells: correlation with re-expression of alpha-catenin and restoration of E-cadherin functionCancer Res 55(21):4813–4817

    PubMed  CAS  Google Scholar 

  17. Lowy AM, Knight J, Groden J (2002) Restoration of E-cadherin/beta-catenin expression in pancreatic cancer cells inhibits growth by induction of apoptosisSurgery 132(2):141–148

    Article  PubMed  Google Scholar 

  18. Daniel CW, Strickland P, Friedmann Y (1995) Expression and functional role of E- and P-cadherins in mouse mammary ductal morphogenesis and growthDev Biol 169(2):511–519

    Article  PubMed  CAS  Google Scholar 

  19. Palacios J, Benito N, Pizarro A, Suarez A, Espada J, Cano A, Gamallo C (1995) Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological featuresAm J Pathol 146(3):605–612

    PubMed  CAS  Google Scholar 

  20. Berx G, Van Roy F (2001) The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progressionBreast Cancer Res(3):289–293

    Google Scholar 

  21. St Croix B, Sheehan C, Rak JW, Florenes VA, Slingerland JM, Kerbel RS (1998) E-Cadherin-dependent growth suppression is mediated by the cyclin- dependent kinase inhibitor p27(KIP1)J Cell Biol 142(2):557–571

    Article  PubMed  CAS  Google Scholar 

  22. Soriano JV, Pepper MS, Nakamura T, Orci L, Montesano R (1995) Hepatocyte growth factor stimulates extensive development of branching duct-like structures by cloned mammary gland epithelial cellsJ Cell Sci 108:413–430

    PubMed  CAS  Google Scholar 

  23. Montesano R, Soriano JV, Fialka I, Orci L (1998) Isolation of EpH4 mammary epithelial cell subpopulations which differ in their morphogenetic propertiesIn vitro Cell Devel Biol-Animal 34:468–477

    Article  CAS  Google Scholar 

  24. Salmon P, Kindler V, Ducrey O, Chapuis B, Zubler RH, Trono D (2000) High-level transgene expression in human hematopoietic progenitors and differentiated blood lineages after transduction with improved lentiviral vectorsBlood 96(10):3392–3398

    PubMed  CAS  Google Scholar 

  25. Gossen M, Bujard H (1992) Tight control of gene expression in mammalian cells by tetracyclin-responsive promotersProc Natl Acad Sci USA 89:5547–5551

    Article  PubMed  CAS  Google Scholar 

  26. Gossen M, Freundlieb S, Bender G, Muller G, Hillen W, Bujard H (1995) Transcriptional activation by tetracyclines in mammalian cellsScience 268:1766–1769

    Article  PubMed  CAS  Google Scholar 

  27. Pecker I, Avraham KB, Gilbert DJ, Savitsky K, Rotman G, Harnik R, Fukao T, Schrock E, Hirotsune S, Tagle DA, Collins FS, Wynshaw-Boris A, Ried T, Copeland NG, Jenkins NA, Shiloh Y, Ziv Y (1996) Identification and chromosomal localization of Atm, the mouse homolog of the ataxia-telangiectasia geneGenomics 35(1):39–45

    Article  PubMed  CAS  Google Scholar 

  28. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vectorScience 272(5259):263–267

    Article  PubMed  CAS  Google Scholar 

  29. Zufferey R, Nagy D, Mandel RJ, Naldini L, Trono D (1997) Multiply attenuated lentiviral vector achieves efficient gene delivery in vivoNat Biotechnol 15:871–875

    Article  PubMed  CAS  Google Scholar 

  30. PE Applied Biosystems User Bulletin #2, 1997

  31. Soriano JV, Pepper MS, Orci L, Montesano R (1998) Roles of hepatocyte growth factor/scatter factor and transforming growth factor-beta1 in mammary gland ductal morphogenesisJ Mammary Gland Biol Neoplasia 3(2):133–150

    Article  PubMed  CAS  Google Scholar 

  32. Morgan SE, Lovly C, Pandita TK, Shiloh Y, Kastan MB (1997) Fragments of ATM which have dominant-negative or complementing activityMol Cell Biol 17(4):2020–2029

    PubMed  CAS  Google Scholar 

  33. Muise-Helmericks RC, Grimes HL, Bellacosa A, Malstrom SE, Tsichlis PN, Rosen N (1998) Cyclin D expression is controlled post-transcriptionally via a phosphatidylinositol 3-kinase/Akt-dependent pathwayJ Biol Chem 273(45):29864–29872

    Article  PubMed  CAS  Google Scholar 

  34. Levenberg S, Yarden A, Kam Z, Geiger B (1999) p27 is involved in N-cadherin-mediated contact inhibition of cell growth and S-phase entryOncogene 18(4):869–876

    Article  PubMed  CAS  Google Scholar 

  35. Nakatsuji Y, Miller RH (2001) Density dependent modulation of cell cycle protein expression in astrocytesJ Neurosci Res 66(3):487–496

    Article  PubMed  CAS  Google Scholar 

  36. Rotman G, Shiloh Y (1997) The ATM gene and protein: possible roles in genome surveillance, checkpoint controls and cellular defence against oxidative stressCancer Surv 29:285–304

    PubMed  CAS  Google Scholar 

  37. Rouault JP, Falette N, Guehenneux F, Guillot C, Rimokh R, Wang Q, Berthet C, Moyret-Lalle C, Savatier P, Pain B, Shaw P, Berger R, Samarut J, Magaud JP, Ozturk M, Samarut C, Puisieux A (1997) Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathwayNat Genet 14(4):482–488

    Article  Google Scholar 

  38. Taylor WR, Agarwal ML, Agarwal A, Stacey DW, Stark GR (1999) p53 inhibits entry into mitosis when DNA synthesis is blockedOncogene 18(2):283–295

    Article  PubMed  CAS  Google Scholar 

  39. Muller KM, Luedecker CJ, Udey MC, Farr AG (1997) Involvement of E-cadherin in thymus organogenesis and thymocyte maturationImmunity 6(3):257–264

    Article  PubMed  CAS  Google Scholar 

  40. Karecla PI, Bowden SJ, Green SJ, Kilshaw PJ (1995) Recognition of E-cadherin on epithelial cells by the mucosal T cell integrin alpha M290 beta 7 (alpha E beta 7)Eur J Immunol 25(3):852–856

    Article  PubMed  CAS  Google Scholar 

  41. Shiloh Y (2001) ATM (ataxia telangiectasia mutated): expanding roles in the DNA damage response and cellular homeostasisBiochem Soc Trans 29(Pt 6):661–666

    Article  PubMed  CAS  Google Scholar 

  42. Abbate M, Remuzzi G (1996) Acceleration of recovery in acute renal failure: from cellular mechanisms of tubular repair to innovative targeted therapiesRen Fail 18(3):377–388

    Article  PubMed  CAS  Google Scholar 

  43. Filipak M, Estervig DN, Tzen CY, Minoo P, Hoerl BJ, Maercklein PB, Zschunke MA, Edens M, Scott RE (1989) Integrated control of proliferation and differentiation of mesenchymal stem cellsEnviron Health Perspect 80:117–125

    Article  PubMed  CAS  Google Scholar 

  44. Vizirianakis IS, Chen YQ, Kantak SS, Tsiftsoglou AS, Kramer RH (2002) Dominant-negative E-cadherin alters adhesion and reverses contact inhibition of growth in breast carcinoma cellsInt J Oncol 21(1):135–144

    PubMed  CAS  Google Scholar 

  45. Calaf G, Russo J, Tait L, Estrad S, Alvarado ME (2000) Morphological phenotypes in neoplastic progression of human breast epithelial cellsJ Submicrosc Cytol Pathol 32(1):83–96

    PubMed  CAS  Google Scholar 

  46. Delia D, Mizutani S, Panigone S, Tagliabue E, Fontanella E, Asada M, Yamada T, Taya Y, Prudente S, Saviozzi S, Frati L, Pierotti MA, Chessa L (2000) ATM protein and p53-serine 15 phosphorylation in ataxia-telangiectasia (AT) patients and at heterozygotesBr J Cancer 82(12):1938–1945

    Article  PubMed  CAS  Google Scholar 

  47. Yang DQ, Kastan MB (2000) Participation of ATM in insulin signalling through phosphorylation of eIF-4E-binding protein 1Nat Cell Biol 2(12):893–898

    Article  PubMed  CAS  Google Scholar 

  48. El-Bahrawy MA, Pignatelli M (1998) E-cadherin and catenins: molecules with versatile roles in normal and neoplastic epithelial cell biologyMicrosc Res Tech 43(3):224–232

    Article  PubMed  CAS  Google Scholar 

  49. Athma P, Rappaport R, Swift M (1996) Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancerCancer Genet Cytogenet 92(2):130–134

    Article  PubMed  CAS  Google Scholar 

  50. Wang Y, Cortez D, Yazdi P, Neff N, Elledge SJ, Qin J (2000). BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structuresGenes Dev 14(8):927–939

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank Y. Shiloh (Tel Aviv University, Israel) for providing the ATM 15-1 clone.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Geneviève Vaudan Vutskits.

Additional information

Financial support: This work was supported by the Swiss National Foundation Grant (Bern, Switzerland) 3100-063553.00/1 to André-Pascal Sappino

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vutskits, G.V., Salmon, P., Mayor, L. et al. A role for atm in E-cadherin-mediated contact inhibition in epithelial cells. Breast Cancer Res Treat 99, 143–153 (2006). https://doi.org/10.1007/s10549-006-9195-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-006-9195-y

Keywords

Navigation